MarketPulse

diabetes management

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Senseonics Holdings, Inc.

Senseonics' Eversense 365 Proves Durable: Real-World Data Shows 94% Wear Rate, Strong Glucose Control

Senseonics reports real-world data from 5,059 Eversense 365 CGM users showing 93.8% wear time and strong glucose control metrics over one year.
SENSmedical devicediabetes management
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

IV Infusion Pump Market to Double to $14B by 2035 on Aging, Tech Gains

Global IV infusion pump market projected to grow from $6.72B in 2025 to $14.02B by 2035 at 7.6% CAGR, driven by aging populations and smart pump technology.
MDTTNDMBAXBDXICUImedical deviceshealthcare market
BenzingaBenzinga··Prnewswire

Global Diabetes Survey Reveals Market Gap: 80% Demand Predictive Tools Beyond CGM

Survey of 4,326 diabetics across 22 countries shows 80% demand predictive glucose forecasting tools, revealing unmet market need beyond current continuous glucose monitoring.
RHHBYhealthcare technologyType 1 diabetes
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Trinity Biotech Given 180 Days to Meet Nasdaq Listing Standards on Share Value

Trinity Biotech received a Nasdaq non-compliance notice for failing to maintain minimum share value requirements. The company has 180 days to restore compliance or face delisting.
TRIBbiotechnologyNasdaq non-compliance